inclusion criteria: * patients over 18 years of age. * with sars-cov-2 infection confirmed by specific pcr. * with clinical manifestations of the infection, such as fever or cough, or otolaryngologic (orl) signs or respiratory difficulties, that started less than 7 days ago. * covid-19 specific treatment-naive. * women of childbearing age should accept the use of mechanical contraception during the study period. * informed consent signed by the patient.

inclusion criteria: * patients over 18 years of age. * with sars-cov-2 infection confirmed by specific pcr. * with clinical manifestations of the infection, such as fever or cough, or otolaryngologic (orl) signs or respiratory difficulties, that started less than 7 days ago. * covid-19 specific treatment-naive. * women of childbearing age should accept the use of mechanical contraception during the study period. * informed consent signed by the patient.

inclusion criteria: - patients over 18 years of age. - with sars-cov-2 infection confirmed by specific pcr. - with clinical manifestations of the infection, such as fever or cough, or otolaryngologic (orl) signs or respiratory difficulties, that started less than 7 days ago. - covid-19 specific treatment-naive. - women of childbearing age should accept the use of mechanical contraception during the study period. - informed consent signed by the patient.

inclusion criteria: - patients over 18 years of age. - with sars-cov-2 infection confirmed by specific pcr. - with clinical manifestations of the infection, such as fever or cough, or otolaryngologic (orl) signs or respiratory difficulties, that started less than 7 days ago. - covid-19 specific treatment-naive. - women of childbearing age should accept the use of mechanical contraception during the study period. - informed consent signed by the patient.